Skip to Content

Desirudin use while Breastfeeding

Drugs containing Desirudin: Iprivask

Medically reviewed by Drugs.com. Last updated on April 13, 2021.

Desirudin Levels and Effects while Breastfeeding

Summary of Use during Lactation

Desirudin is no longer marketed in the United States. Because no information is available on the use of desirudin during breastfeeding, an alternate drug is preferred.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Acenocoumarol, Dalteparin, Enoxaparin, Heparin, Rivaroxaban, Warfarin

Substance Identification

Substance Name

Desirudin

CAS Registry Number

120993-53-5

Drug Class

Breast Feeding

Lactation

Anticoagulants

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.